| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $118,469,952 ) (Continued on the next page) |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | U01AI159087 | Multi-omics of the Frequent Exacerbator Asthmatic | 001 | 6 | NIH | 6/8/2026 | $0 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | U01AI159087 | Multi-omics of the Frequent Exacerbator Asthmatic | 000 | 6 | NIH | 4/10/2026 | $446,685 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01HL158100 | Effect of reproductive history on longitudinal change in cardiac, vascular and lipid parameters | 001 | 5 | NIH | 3/30/2026 | $20,322 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01HL158100 | Effect of reproductive history on longitudinal change in cardiac, vascular and lipid parameters | 000 | 5 | NIH | 2/12/2026 | $643,567 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01NS125316 | Understanding the Impact of Youth Onset Obesity and Type 2 Diabetes on the Neurovascular Unit | 000 | 5 | NIH | 3/19/2026 | $372,200 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01NS125316 | Understanding the Impact of Youth Onset Obesity and Type 2 Diabetes on the Neurovascular Unit | 000 | 5 | NIH | 3/19/2026 | $78,949 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | K08GM148957 | Mechanisms of cardiomyocyte dysfunction in pediatric septic shock | 000 | 4 | NIH | 1/27/2026 | $192,024 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01AR083368 | Development and optimization of skeletal muscle delivery vehicles | 000 | 3 | NIH | 6/11/2026 | $498,796 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01HL169242 | Allogeneic virus-specific T-cell therapy after hematopoietic stem cell transplant: determinants of treatment success and failure | 000 | 3 | NIH | 5/26/2026 | $633,324 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | F31HL172346 | Effects of early Retinoic Acid signaling on valve development | 001 | 3 | NIH | 5/5/2026 | $576 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | F31HL172346 | Effects of early Retinoic Acid signaling on valve development | 000 | 3 | NIH | 2/24/2026 | $42,479 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R33HL166441 | Intramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent Rheumatic Heart Disease: A non-inferiority randomized trial. (GOALIE) | 003 | 4 | NIH | 2/24/2026 | $135,660 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R33HL166441 | Intramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent Rheumatic Heart Disease: A non-inferiority randomized trial. (GOALIE) | 009 | 4 | NIH | 4/3/2026 | $680,919 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R33HL166441 | Intramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent Rheumatic Heart Disease: A non-inferiority randomized trial. (GOALIE) | 002 | 4 | NIH | 2/23/2026 | $62,634 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R33HL166441 | Intramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent Rheumatic Heart Disease: A non-inferiority randomized trial. (GOALIE) | 008 | 4 | NIH | 4/2/2026 | $135,660 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R33HL166441 | Intramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent Rheumatic Heart Disease: A non-inferiority randomized trial. (GOALIE) | 001 | 4 | NIH | 2/20/2026 | $680,919 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R33HL166441 | Intramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent Rheumatic Heart Disease: A non-inferiority randomized trial. (GOALIE) | 007 | 4 | NIH | 4/2/2026 | $62,634 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R33HL166441 | Intramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent Rheumatic Heart Disease: A non-inferiority randomized trial. (GOALIE) | 000 | 4 | NIH | 2/17/2026 | $643,153 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R33HL166441 | Intramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent Rheumatic Heart Disease: A non-inferiority randomized trial. (GOALIE) | 006 | 4 | NIH | 4/2/2026 | -$680,919 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R33HL166441 | Intramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent Rheumatic Heart Disease: A non-inferiority randomized trial. (GOALIE) | 005 | 4 | NIH | 3/31/2026 | -$135,660 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R33HL166441 | Intramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent Rheumatic Heart Disease: A non-inferiority randomized trial. (GOALIE) | 004 | 4 | NIH | 3/31/2026 | -$62,634 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01HL105924 | Thrombospondin 4 regulates adaptive ER stress responseRenewal - Resubmission - 1 | 000 | 15 | NIH | 2/24/2026 | $566,138 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R21HL184196 | Integrative multiomics prediction of fetal origins and perturbations for chILD | 001 | 1 | NIH | 4/29/2026 | $120,375 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R21HL184196 | Integrative multiomics prediction of fetal origins and perturbations for chILD | 000 | 1 | NIH | 4/8/2026 | $120,375 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01AI182167 | Animal Models to Develop New Regimens for S. aureus Implant-Associated Infections | 001 | 2 | NIH | 2/17/2026 | $3,266,329 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R21AG098113 | Proteomic identification of nuclear rupture-associated proteins in laminopathy hearts | 000 | 1 | NIH | 5/11/2026 | $445,500 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01DK146906 | Regulatory CD4+ T (Treg) cells dynamics in the pathogenesis of metabolic dysfunction-associated steatotic liver disease (MASLD) | 000 | 1 | NIH | 6/23/2026 | $714,898 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R21HD121139 | Defining how dominant-negative RBPJ disease alleles impact Notch outcomes | 000 | 1 | NIH | 5/7/2026 | $445,500 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01DK145648 | From real-world evidence to systems pharmacology: a comprehensive approach to drug-induced pancreatic injury | 000 | 1 | NIH | 3/24/2026 | $824,078 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01DK146438 | Mechanisms regulating competency of hepatocyte plasticity | 000 | 1 | NIH | 2/10/2026 | $851,275 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | F32AI191748 | Role of Growth Hormone and STAT2 in Modulating Neuroimmune Signaling and Mast Cell Recruitment in Neonatal Inflammatory Pain. | 001 | 1 | NIH | 4/3/2026 | $0 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | F32AI191748 | Role of Growth Hormone and STAT2 in Modulating Neuroimmune Signaling and Mast Cell Recruitment in Neonatal Inflammatory Pain. | 000 | 1 | NIH | 4/3/2026 | $84,148 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | UM1TR006070 | Patient-specific, combinatorial NAMs for gastrointestinal diseases and drug response prediction | 000 | 1 | NIH | 2/9/2026 | $3,240,000 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R00HL171830 | Frontiers at the edge: Subpleural fibroblasts orchestrate pulmonary fibrosis progression | 000 | 3 | NIH | 4/6/2026 | $249,000 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01MH139504 | Impact of Circadian Misalignment for Adolescents with ADHD: Observational and Mechanistic Data | 000 | 1 | NIH | 3/5/2026 | $820,196 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | K23HL179415 | Longitudinal Examination of Food Insecurity and Cardiometabolic Health Risk in Hispanic/Latino Adolescents | 000 | 1 | NIH | 4/2/2026 | $191,636 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | F31HL179869 | The contribution of JNK signaling to development of EPR dysfunction in primary hypertension | 001 | 1 | NIH | 5/5/2026 | $576 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | F31HL179869 | The contribution of JNK signaling to development of EPR dysfunction in primary hypertension | 000 | 1 | NIH | 3/27/2026 | $42,479 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R13CA313846 | The International Workshop on Molecular Aspects of Myeloid Stem Cell Development and Leukemia | 000 | 1 | NIH | 5/5/2026 | $10,000 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R13CA313846 | The International Workshop on Molecular Aspects of Myeloid Stem Cell Development and Leukemia | 000 | 1 | NIH | 5/5/2026 | $5,000 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R13CA313846 | The International Workshop on Molecular Aspects of Myeloid Stem Cell Development and Leukemia | 000 | 1 | NIH | 5/5/2026 | $5,000 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01AG093208 | The Effect of DDX41 Mutations on Hematopoiesis During Aging | 001 | 1 | NIH | 4/3/2026 | $5,185 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01AG093208 | The Effect of DDX41 Mutations on Hematopoiesis During Aging | 000 | 1 | NIH | 3/27/2026 | $640,060 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R21AI188683 | Contribution of adipose tissue immune cells to Influenza pathogenesis | 000 | 2 | NIH | 6/25/2026 | $200,625 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | K23HD118188 | Effects of Bioactive Components in Donor Milk on Preterm Infant Growth | 000 | 1 | NIH | 5/14/2026 | $165,240 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01MH138336 | Cognitive Disengagement Syndrome: A Transdiagnostic Predictor of Psychopathology Across Adolescence | 000 | 1 | NIH | 5/4/2026 | $802,494 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01HL180559 | The Impact of SLC26A9 on Response to CFTR Correction | 000 | 2 | NIH | 6/11/2026 | $717,742 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01HD068524 | Molecular signaling in uterine receptivity to implantation | 002 | 14 | NIH | 2/27/2026 | $439,064 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01HD093754 | Cognitive Outcome Measures in School Age Children with Down Syndrome (ECODS) | 000 | 8 | NIH | 7/1/2026 | $878,666 |
|
